Literature DB >> 14602266

The incidence of dysphagia in pediatric patients after open heart procedures with transesophageal echocardiography.

Lisa M Kohr1, Margaret Dargan, Amy Hague, Suzanne P Nelson, Elise Duffy, Carl L Backer, Constantine Mavroudis.   

Abstract

BACKGROUND: Pediatric patients who undergo open heart operations may be at risk for the development of dysphagia because of interventions such as intubation and transesophageal echocardiography. Although the occurrence of dysphagia after cardiac surgical procedures in adults is reported to be 3% to 4%, the incidence in children and adolescents has not been documented. This study was undertaken to determine the incidence of and risk factors contributing to dysphagia in pediatric patients after open heart procedures.
METHODS: Fifty patients were evaluated after open heart operations with transesophageal echocardiography between March 1, 1999, and September 30, 1999. The diagnosis of dysphagia was made by a speech pathologist using a clinical swallowing evaluation. Potential predictors examined included demographic variables, anatomical diagnosis, surgical procedure, size of the transesophageal echocardiographic probe in relation to body size, length of probe insertion time, preoperative patient acuity status, duration of intubation, and time until discharge.
RESULTS: Dysphagia was found in 9 (18%) of the 50 patients. Risk factors identified were age of less than 3 years (odds ratio, 20.4; 95% confidence interval, 2.7 to 157; p = 0.002), intubation prior to operation (odds ratio, 17.7; 95% confidence interval, 9.4 to 210; p = 0.004), intubation for more than 7 days (odds ratio, 74.7; 95% confidence interval, 13.8 to 405; p = 0.001), and operation for left-sided obstructive lesions (odds ratio, 1.9; 95% confidence interval, 2.2 to 8.3; p = 0.038). The size of the transesophageal echocardiographic probe in relation to the weight of the patient was found to be predictive (p = 0.0001) of dysphagia. Vocal cord paralysis was noted in 4 (8%) of the 50 patients postoperatively. Adverse events related to aspiration occurred in 2 patients (4%). At discharge, nasogastric tube feedings were required in 6 patients (12%), and thickened feedings were recommended for 3 (6%) of the 50 patients. Resolution of dysphagia ranged from 13 to 150 days.
CONCLUSIONS: Eighteen percent of patients had dysphagia after an open heart operation with transesophageal echocardiography. Age of less than 3 years, preoperative patient acuity status, longer intubation times, and operation for left-sided obstructions are risk factors for dysphagia in this cohort of pediatric patients. The size of the transesophageal echocardiography probe in relation to the patient's weight was predictive of dysphagia. Physicians should consider using the new mini-multiplane transesophageal echocardiographic probes in patients weighing less than 5.5 kg. Vigilance in monitoring for the signs of preoperative and postoperative dysphagia with prompt referral to a speech therapist can substantially reduce patient morbidity, length of hospital stay, and requirement of prolonged nasogastric tube use.

Entities:  

Mesh:

Year:  2003        PMID: 14602266     DOI: 10.1016/s0003-4975(03)00956-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

Review 1.  Echocardiographic guidance of transcatheter closure of atrial septal defects: is intracardiac echocardiography better than transesophageal echocardiography?

Authors:  P Koenig; Q L Cao
Journal:  Pediatr Cardiol       Date:  2005 Mar-Apr       Impact factor: 1.655

2.  Total Energy Expenditure of Infants with Congenital Heart Disease Who Have Undergone Surgical Intervention.

Authors:  Jillian C Trabulsi; S Y Irving; M A Papas; C Hollowell; C Ravishankar; B S Marino; B Medoff-Cooper; J I Schall; V A Stallings
Journal:  Pediatr Cardiol       Date:  2015-06-21       Impact factor: 1.655

3.  Creation of a Standard Model for Tube Feeding at Neonatal Intensive Care Unit Discharge.

Authors:  Benjamin R White; Anna Ermarth; Debbie Thomas; Olivia Arguinchona; Angela P Presson; Con Yee Ling
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-09-24       Impact factor: 4.016

4.  Transoesophageal echocardiography related complications.

Authors:  S K Mathur; Pooja Singh
Journal:  Indian J Anaesth       Date:  2009-10

5.  Vocal cord paralysis and Dysphagia after aortic arch reconstruction and Norwood procedure.

Authors:  Vinh Pham; Diana Connelly; Julie L Wei; Kevin J Sykes; Jim O'Brien
Journal:  Otolaryngol Head Neck Surg       Date:  2014-02-10       Impact factor: 3.497

6.  Resting energy expenditure at 3 months of age following neonatal surgery for congenital heart disease.

Authors:  Sharon Y Irving; Barbara Medoff-Cooper; Nicole O Stouffer; Joan I Schall; Chitra Ravishankar; Charlene W Compher; Bradley S Marino; Virginia A Stallings
Journal:  Congenit Heart Dis       Date:  2013-01-30       Impact factor: 2.007

7.  Evaluation of swallowing in infants with congenital heart defect.

Authors:  Karine da Rosa Pereira; Cora Firpo; Marisa Gasparin; Adriane Ribeiro Teixeira; Silvia Dornelles; Tzvi Bacaltchuk; Deborah Salle Levy
Journal:  Int Arch Otorhinolaryngol       Date:  2014-11-05

8.  Prospective evaluation of complications associated with transesophageal echocardiography in dogs with congenital heart disease.

Authors:  Caitlin H Stoner; Ashley B Saunders; Johanna C Heseltine; Audrey K Cook; Jonathan A Lidbury
Journal:  J Vet Intern Med       Date:  2022-01-08       Impact factor: 3.333

9.  Analysis of Vocal Fold Motion Impairment in Neonates Undergoing Congenital Heart Surgery.

Authors:  Stephanie E Ambrose; Julina Ongkasuwan; Kavita Dedhia; Gillian R Diercks; Samantha Anne; Subhadra Shashidharan; Nikhila Raol
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-05-01       Impact factor: 6.223

Review 10.  Rehabilitation in Pediatric Heart Failure and Heart Transplant.

Authors:  Ana Ubeda Tikkanen; Emily Berry; Erin LeCount; Katherine Engstler; Meredith Sager; Paul Esteso
Journal:  Front Pediatr       Date:  2021-05-19       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.